Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |